These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 19284741)

  • 1. Mechanisms of antagonism of the GluR2 AMPA receptor: structure and dynamics of the complex of two willardiine antagonists with the glutamate binding domain.
    Ahmed AH; Thompson MD; Fenwick MK; Romero B; Loh AP; Jane DE; Sondermann H; Oswald RE
    Biochemistry; 2009 May; 48(18):3894-903. PubMed ID: 19284741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural requirements for novel willardiine derivatives acting as AMPA and kainate receptor antagonists.
    More JC; Troop HM; Dolman NP; Jane DE
    Br J Pharmacol; 2003 Mar; 138(6):1093-100. PubMed ID: 12684265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal structures of the kainate receptor GluR5 ligand binding core dimer with novel GluR5-selective antagonists.
    Mayer ML; Ghosal A; Dolman NP; Jane DE
    J Neurosci; 2006 Mar; 26(11):2852-61. PubMed ID: 16540562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The structure of a mixed GluR2 ligand-binding core dimer in complex with (S)-glutamate and the antagonist (S)-NS1209.
    Kasper C; Pickering DS; Mirza O; Olsen L; Kristensen AS; Greenwood JR; Liljefors T; Schousboe A; Wätjen F; Gajhede M; Sigurskjold BW; Kastrup JS
    J Mol Biol; 2006 Apr; 357(4):1184-201. PubMed ID: 16483599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of partial agonism at the GluR2 AMPA receptor: Measurements of lobe orientation in solution.
    Maltsev AS; Ahmed AH; Fenwick MK; Jane DE; Oswald RE
    Biochemistry; 2008 Oct; 47(40):10600-10. PubMed ID: 18795801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of willardiine and 6-azawillardiine analogs: pharmacological characterization on cloned homomeric human AMPA and kainate receptor subtypes.
    Jane DE; Hoo K; Kamboj R; Deverill M; Bleakman D; Mandelzys A
    J Med Chem; 1997 Oct; 40(22):3645-50. PubMed ID: 9357531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thermodynamics and mechanism of the interaction of willardiine partial agonists with a glutamate receptor: implications for drug development.
    Martinez M; Ahmed AH; Loh AP; Oswald RE
    Biochemistry; 2014 Jun; 53(23):3790-5. PubMed ID: 24850223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms for activation and antagonism of an AMPA-sensitive glutamate receptor: crystal structures of the GluR2 ligand binding core.
    Armstrong N; Gouaux E
    Neuron; 2000 Oct; 28(1):165-81. PubMed ID: 11086992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of 5'-GMP to the GluR2 AMPA receptor: insight from targeted molecular dynamics simulations.
    Mendieta J; Gago F; Ramírez G
    Biochemistry; 2005 Nov; 44(44):14470-6. PubMed ID: 16262247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and pharmacological characterization of N3-substituted willardiine derivatives: role of the substituent at the 5-position of the uracil ring in the development of highly potent and selective GLUK5 kainate receptor antagonists.
    Dolman NP; More JC; Alt A; Knauss JL; Pentikäinen OT; Glasser CR; Bleakman D; Mayer ML; Collingridge GL; Jane DE
    J Med Chem; 2007 Apr; 50(7):1558-70. PubMed ID: 17348638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microsecond-to-millisecond conformational dynamics demarcate the GluR2 glutamate receptor bound to agonists glutamate, quisqualate, and AMPA.
    Valentine ER; Palmer AG
    Biochemistry; 2005 Mar; 44(9):3410-7. PubMed ID: 15736951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and pharmacology of willardiine derivatives acting as antagonists of kainate receptors.
    Dolman NP; Troop HM; More JC; Alt A; Knauss JL; Nistico R; Jack S; Morley RM; Bortolotto ZA; Roberts PJ; Bleakman D; Collingridge GL; Jane DE
    J Med Chem; 2005 Dec; 48(24):7867-81. PubMed ID: 16302825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3-hydroxypyridazine 1-oxides as carboxylate bioisosteres: a new series of subtype-selective AMPA receptor agonists.
    Greenwood JR; Mewett KN; Allan RD; Martín BO; Pickering DS
    Neuropharmacology; 2006 Jul; 51(1):52-9. PubMed ID: 16631211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NMR spectroscopy of the ligand-binding core of ionotropic glutamate receptor 2 bound to 5-substituted willardiine partial agonists.
    Fenwick MK; Oswald RE
    J Mol Biol; 2008 May; 378(3):673-85. PubMed ID: 18387631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AMPA receptor ligand binding domain mobility revealed by functional cross linking.
    Plested AJ; Mayer ML
    J Neurosci; 2009 Sep; 29(38):11912-23. PubMed ID: 19776277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The loss of an electrostatic contact unique to AMPA receptor ligand binding domain 2 slows channel activation.
    Holley SM; Ahmed AH; Srinivasan J; Murthy SE; Weiland GA; Oswald RE; Nowak LM
    Biochemistry; 2012 May; 51(19):4015-27. PubMed ID: 22512472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydrophobic side chain dynamics of a glutamate receptor ligand binding domain.
    Maltsev AS; Oswald RE
    J Biol Chem; 2010 Mar; 285(13):10154-10162. PubMed ID: 20110365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of a negative allosteric modulator and competitive antagonist can occur simultaneously at the ionotropic glutamate receptor GluA2.
    Krintel C; Dorosz J; Larsen AH; Thorsen TS; Venskutonytė R; Mirza O; Gajhede M; Boesen T; Kastrup JS
    FEBS J; 2021 Feb; 288(3):995-1007. PubMed ID: 32543078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The novel antagonist 3-CBW discriminates between kainate receptors expressed on neonatal rat motoneurones and those on dorsal root C-fibres.
    More JC; Troop HM; Jane DE
    Br J Pharmacol; 2002 Dec; 137(7):1125-33. PubMed ID: 12429586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stargazin modulates AMPA receptor antagonism.
    Cokić B; Stein V
    Neuropharmacology; 2008 Jun; 54(7):1062-70. PubMed ID: 18378265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.